ID
29931
Beskrivning
Study ID: 102123 Clinical Study ID: FFR102123 Study Title: A randomised double-blind placebo controlled parallel group multicentre long term study to evaluate the safety of once-daily, intranasal administration of GW685698X aqueous nasal spray 100mcg* for 52 weeks in adult and adolescent subjects with perennial allergic rhinitis. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone furoate Trade Name: FLUTIDE, Allermist, Veramyst, FLUNASE, FLIXOTAIDE, FLUTAIDE, FLIXOVATE, Avamys; Veramyst, Avamys, Allermist Study Indication: Rhinitis, Allergic, Perennial This ODM-file contains Repeat 12-lead-ECG.
Nyckelord
Versioner (1)
- 2018-04-27 2018-04-27 - Sarah Riepenhausen
Rättsinnehavare
GlaxoSmithKline
Uppladdad den
27 april 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Safety of once-daily administration of Fluticasone nasal spray in adults and adolescents with perennial allergic rhinitis GSK 102123
Similar models
Repeat 12-lead-ECG
- StudyEvent: ODM
C0205341 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0205341 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,3])
C0205341 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1274040 (UMLS CUI [1,2])
C0392747 (UMLS CUI [1,3])